Sugi Predict

Sugi Predict / Compounds / SCHEMBL1759453

SCHEMBL1759453

SCHEMBL1759453

Oc1cc(O)nc(C(F)(F)F)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE2 O96020 4/20 0.36
▸ CCNE1 P24864 4/20 0.36
▸ CDK2 P24941 4/20 0.36
▸ CDK4 P11802 3/20 0.36
▸ CCND1 P24385 3/20 0.36
▸ HTT P42858 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL601042 0.85 HSP90AA1 (0.36) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL10889888 0.84 HSP90AA1 (0.39) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL2441449 0.84 BACE1 (0.35) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL30755776 0.79 MEN1 (0.33) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL6826481 0.79 KDM4E (0.36) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL6122066 0.74 GABRA5 (0.39) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL30756004 0.74 ESR1 (0.30) —
SCHEMBL8999929 0.72 CES2 (0.42) KDM4EMAPT
SCHEMBL1221655 0.72 ALDH1A1 (0.38) HTTKDM4EMAPTMEN1POLB
SCHEMBL175478 0.71 ALDH1A1 (0.33) CCNE2CCNE1CDK2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1032916-C Process for large-scale production of 1-[(1-(2-(trifluoromethyl)-4-pyrimidinyl]-4-piperidinyl] methyl]-2-pyrrolidone BRISTOL MYERS SQUIBB CO (US) 1996-10-02 — — CN claimed
CN-1051175-A 1-[[1-[2-(trifluoromethyl)-4-pyrimidyl]-the 4-piperidyl] methyl]-large-scale producing method of 2-Pyrrolidone BRISTOL MYERS SQUIBB CO (US) 1991-05-08 — — CN claimed
US-12610730-B2 Metal complex and light emitting device CITY UNIVERSITY OF HONG KONG (HK) 2026-04-21 — — US disclosed
CN-119638635-A Synthesis method of compound 4-hydroxy-2-trifluoromethyl pyrimidine 上海毕得医药科技股份有限公司 2025-03-18 — — CN disclosed
CN-114455557-B Method for recovering phosphorus oxychloride in chlorination reaction of hydroxyl-containing compound 江苏中旗科技股份有限公司 2023-04-28 — — CN disclosed
US-20230006152-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE CITY UNIVERSITY OF HONG KONG (HK) 2023-01-05 — — US disclosed
US-20230006152-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE CITY UNIVERSITY OF HONG KONG (HK) 2023-01-05 — — US disclosed
US-20220402955-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE CITY UNIVERSITY OF HONG KONG (HK) 2022-12-22 — — US disclosed
US-20220402955-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE CITY UNIVERSITY OF HONG KONG (HK) 2022-12-22 — — US disclosed
CN-114455557-A Method for recovering phosphorus oxychloride in chlorination reaction of hydroxyl compound 江苏中旗科技股份有限公司 2022-05-10 — — CN disclosed
CN-106883185-B Preparation method of 4-chloro-2-trifluoromethylpyrimidine 重庆博腾制药科技股份有限公司 2021-07-09 — — CN disclosed
EP-1730122-A2 PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-12-13 — — EP disclosed
WO-2005095357-A2 PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-10-13 — — WO disclosed
CN-1135227-C 2,6-twice substituted pyridine and 2,4-twice substituted pyrimidine for berbicide 谷 2004-01-21 — — CN disclosed
CN-1117748-C Herbicidal 2, 6 -disubstituted pyridines and 2, 4 -disubstituted pyrimidines AMERICAN CYANAMID CO (US) 2003-08-13 — — CN disclosed
CN-1175578-A Herbicidal 2, 6 -disubstituted pyridines and 2, 4 -disubstituted pyrimidines AMERICAN CYANAMID CO (US) 1998-03-11 — — CN disclosed
CN-1143078-A 2,6-twice substituted pyridine and 2,4-twice substituted pyrimidine for berbicide AMERICAN CYANAMID CO (US) 1997-02-19 — — CN disclosed
CN-1032916-C Process for large-scale production of 1-[(1-(2-(trifluoromethyl)-4-pyrimidinyl]-4-piperidinyl] methyl]-2-pyrrolidone BRISTOL MYERS SQUIBB CO (US) 1996-10-02 — — CN disclosed
CN-1051175-A 1-[[1-[2-(trifluoromethyl)-4-pyrimidyl]-the 4-piperidyl] methyl]-large-scale producing method of 2-Pyrrolidone BRISTOL MYERS SQUIBB CO (US) 1991-05-08 — — CN disclosed
US-4963678-A Process for large-scale production of BMY 21502 BRISTOL-MYERS SQUIBB CO. (US) 1990-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006152-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE OCIAD1, OCIAD2, OPRD1 CCNE2 712/4885CCNE1 2488/4885CDK2 2539/4885
US-12610730-B2 Metal complex and light emitting device OPRD1, OCIAD2, ORC3 CCNE2 1183/4885CCNE1 3329/4885CDK2 3311/4885
US-20220402955-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE OCIAD1, OCIAD2, OSTC CCNE2 590/4885CCNE1 2129/4885CDK2 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.